Hedge Fund - Rock Springs Capital Management
Madrigal Pharmaceuticals Inc. (MDGL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $55,215,379 | 3.16% | 166,698 | $328.59 |
| 2 | 2024 - Q4 (2024-12-31) | $81,836,467 | 3.11% | 265,212 | $281.26 |
| 3 | 2024 - Q3 (2024-09-30) | $55,827,018 | 1.81% | 263,062 | $255.83 |
| 4 | 2024 - Q2 (2024-06-30) | $68,779,000 | 2.07% | 245,499 | $238.04 |
| 5 | 2024 - Q1 (2024-03-31) | $76,355,014 | 1.93% | 285,931 | $235.62 |
| 6 | 2023 - Q4 (2023-12-31) | $45,852,343 | 1.12% | 198,169 | $174.99 |
| 7 | 2023 - Q3 (2023-09-30) | $28,677,729 | 0.76% | 196,369 | $188.22 |
| 8 | 2023 - Q2 (2023-06-30) | $46,019,358 | 1.09% | 199,218 | $270.85 |
| 9 | 2023 - Q1 (2023-03-31) | $84,335,793 | 2.01% | 348,121 | $272.48 |
| 10 | 2022 - Q4 (2022-12-31) | $101,042,120 | 2.43% | 348,121 | $97.80 |
| 11 | 2022 - Q3 (2022-09-30) | $20,633,000 | 0.53% | 317,485 | $69.48 |
| 12 | 2022 - Q2 (2022-06-30) | $22,726,000 | 0.66% | 317,485 | $73.50 |
| 13 | 2022 - Q1 (2022-03-31) | $26,836,000 | 0.67% | 273,500 | $84.31 |
| 14 | 2021 - Q4 (2021-12-31) | $22,829,000 | 0.52% | 269,400 | $82.16 |
| 15 | 2021 - Q3 (2021-09-30) | $20,945,000 | 0.44% | 262,500 | $86.38 |
| 16 | 2021 - Q2 (2021-06-30) | $25,570,000 | 0.5% | 262,500 | $118.38 |
| 17 | 2021 - Q1 (2021-03-31) | $30,237,000 | 0.65% | 258,500 | $116.59 |
| 18 | 2020 - Q4 (2020-12-31) | $28,545,000 | 0.6% | 256,768 | $122.23 |
| 19 | 2020 - Q3 (2020-09-30) | $30,189,000 | 0.76% | 254,268 | $108.57 |
| 20 | 2020 - Q2 (2020-06-30) | $28,796,000 | 0.78% | 254,268 | $98.34 |
| 21 | 2020 - Q1 (2020-03-31) | $16,690,000 | 0.69% | 250,000 | $83.31 |
| 22 | 2019 - Q4 (2019-12-31) | $22,796,000 | 0.72% | 250,200 | $96.98 |
| 23 | 2019 - Q3 (2019-09-30) | $23,486,000 | 0.93% | 272,400 | $93.82 |
| 24 | 2019 - Q2 (2019-06-30) | $26,926,000 | 0.97% | 256,900 | $107.12 |
| 25 | 2019 - Q1 (2019-03-31) | $31,973,000 | 1.23% | 255,250 | $124.30 |
| 26 | 2018 - Q4 (2018-12-31) | $27,166,000 | 1.28% | 241,000 | $154.76 |
| 27 | 2018 - Q3 (2018-09-30) | $73,232,000 | 2.65% | 342,000 | $250.94 |
| 28 | 2018 - Q2 (2018-06-30) | $95,738,000 | 3.68% | 342,300 | $175.60 |
| 29 | 2018 - Q1 (2018-03-31) | $38,015,000 | 1.62% | 325,500 | $123.44 |
| 30 | 2017 - Q4 (2017-12-31) | $31,392,000 | 1.42% | 342,000 | $57.12 |
| 31 | 2017 - Q3 (2017-09-30) | $12,370,000 | 0.57% | 275,000 | $18.72 |
| 32 | 2017 - Q2 (2017-06-30) | $8,780,000 | 0.44% | 540,000 | $15.63 |
| 33 | 2017 - Q1 (2017-03-31) | $3,465,000 | 0.19% | 225,000 | $15.73 |
| 34 | 2016 - Q4 (2016-12-31) | $2,606,000 | 0.17% | 174,891 | $16.07 |
| 35 | 2016 - Q3 (2016-09-30) | $799,000 | 0.05% | 63,000 | $9.69 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:35.0000 on 2016-07-25